Clinical Trial Update: A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of a human monoclonal antibody VRCHIVMAB0115-00-AB (VRC01.23LS) in healthy adults; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRCHIVMAB0115-00-AB (VRC01.23LS) (VRC01.23LS)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2025-08-22